Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000258607

Medchemexpress LLC Oxfbd04 | 2231747-03-6 | 99.0% | C17H16N2O3 | 10MG
SDP

Catalog No. 5000258607
Encompass_Preferred

OXFBD04 is a small-molecule BET bromodomain ligand that inhibits BRD4 and shows modest affinity for the CREBBP bromodomain. It is intended for research use and has reported analytical data including CAS 2231747-03-6, molecular formula C17H16N2O3, molecular weight 296.32, and reported purity ~98.99%.

  • Potent BRD4 inhibitor for epigenetic research.
  • Modest affinity for the CREBBP bromodomain.
  • High reported purity (≈98.99%).
  • Soluble ≥250 mg/mL in DMSO for formulation convenience.
  • Available in small pack sizes suitable for screening.
  • Storage conditions recommended for powder and solution stability.

Catalog No. 50-002-58607 Supplier Medchemexpress LLC Supplier No. HY13523610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

OXFBD04 is a small-molecule BET bromodomain ligand that inhibits BRD4 and shows modest affinity for the CREBBP bromodomain. It is intended for research use and has reported analytical data including CAS 2231747-03-6, molecular formula C17H16N2O3, molecular weight 296.32, and reported purity ~98.99%.

  • Potent BRD4 inhibitor for epigenetic research.
  • Modest affinity for the CREBBP bromodomain.
  • High reported purity (≈98.99%).
  • Soluble ≥250 mg/mL in DMSO for formulation convenience.
  • Available in small pack sizes suitable for screening.
  • Storage conditions recommended for powder and solution stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.